πŸ‡ΊπŸ‡Έ FDA
Patent

US 9474784

Therapeutic applications of SMAD7

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 9474784 (Therapeutic applications of SMAD7) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/7088, A61K38/00, A61K38/162, A61K38/1709